Antimicrobials from a feline commensal bacterium inhibit skin infection by drug-resistant S. pseudintermedius

  1. Alan M O'Neill
  2. Kate A Worthing
  3. Nikhil Kulkarni
  4. Fengwu Li
  5. Teruaki Nakatsuji
  6. Dominic McGrosso
  7. Robert H Mills
  8. Gayathri Kalla
  9. Joyce Y Cheng
  10. Jacqueline M Norris
  11. Kit Pogliano
  12. Joe Pogliano
  13. David J Gonzalez
  14. Richard L Gallo  Is a corresponding author
  1. University of California San Diego, United States
  2. University of Arizona, United States
  3. University of Sydney, Australia
  4. University of California, San Diego, United States

Abstract

Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is an important emerging zoonotic pathogen that causes severe skin infections. To combat infections from drug-resistant bacteria, the transplantation of commensal antimicrobial bacteria as a therapeutic has shown clinical promise. We screened a collection of diverse staphylococcus species from domestic dogs and cats for antimicrobial activity against MRSP. A unique strain (S. felis C4) was isolated from feline skin that inhibited MRSP and multiple gram-positive pathogens. Whole genome sequencing and mass spectrometry revealed several secreted antimicrobials including a thiopeptide bacteriocin micrococcin P1 and phenol-soluble modulin beta (PSMβ) peptides that exhibited antimicrobial and anti-inflammatory activity. Fluorescence and electron microscopy revealed that S. felis antimicrobials inhibited translation and disrupted bacterial but not eukaryotic cell membranes. Competition experiments in mice showed that S. felis significantly reduced MRSP skin colonization and an antimicrobial extract from S. felis significantly reduced necrotic skin injury from MRSP infection. These findings indicate a feline commensal bacterium that could be utilized in bacteriotherapy against difficult-to-treat animal and human skin infections.

Data availability

The RNA Sequencing data has been deposited in Dryad with a unique DOI identifier provided:doi:10.6076/D10019

The following data sets were generated

Article and author information

Author details

  1. Alan M O'Neill

    Dermatology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5892-6477
  2. Kate A Worthing

    Veterinary Medicine, University of Arizona, Arizona, United States
    Competing interests
    Kate A Worthing, Dr. Worthing is a co-inventor of technology described in this manuscript that has been disclosed to the University of California San Diego..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8713-7189
  3. Nikhil Kulkarni

    Dermatology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  4. Fengwu Li

    Dermatology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  5. Teruaki Nakatsuji

    Dermatology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  6. Dominic McGrosso

    Dermatology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  7. Robert H Mills

    Pharmacology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  8. Gayathri Kalla

    Pharmacology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  9. Joyce Y Cheng

    Dermatology, University of California San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  10. Jacqueline M Norris

    Veterinary Science, University of Sydney, Sydney, Australia
    Competing interests
    No competing interests declared.
  11. Kit Pogliano

    Division of Biological Sciences, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7868-3345
  12. Joe Pogliano

    Division of Biological Sciences, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  13. David J Gonzalez

    Department of Pharmacology, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  14. Richard L Gallo

    Dermatology, University of California San Diego, San Diego, United States
    For correspondence
    rgallo@health.ucsd.edu
    Competing interests
    Richard L Gallo, is a co-founder, scientific advisor, consultant and has equity in MatriSys Biosciences and is a consultant, receives income and has equity in Sente.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1401-7861

Funding

National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK007202)

  • Robert H Mills

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Sophie Helaine, Harvard Medical School, United States

Ethics

Animal experimentation: All experiments involving live animal work were performed in accordance with the approval of the University of California, San Diego Institutional Animal Care and Use Guidelines (protocol no. S09074)

Version history

  1. Received: January 22, 2021
  2. Preprint posted: March 8, 2021 (view preprint)
  3. Accepted: October 2, 2021
  4. Accepted Manuscript published: October 19, 2021 (version 1)
  5. Version of Record published: October 21, 2021 (version 2)

Copyright

© 2021, O'Neill et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,607
    views
  • 523
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Alan M O'Neill
  2. Kate A Worthing
  3. Nikhil Kulkarni
  4. Fengwu Li
  5. Teruaki Nakatsuji
  6. Dominic McGrosso
  7. Robert H Mills
  8. Gayathri Kalla
  9. Joyce Y Cheng
  10. Jacqueline M Norris
  11. Kit Pogliano
  12. Joe Pogliano
  13. David J Gonzalez
  14. Richard L Gallo
(2021)
Antimicrobials from a feline commensal bacterium inhibit skin infection by drug-resistant S. pseudintermedius
eLife 10:e66793.
https://doi.org/10.7554/eLife.66793

Share this article

https://doi.org/10.7554/eLife.66793

Further reading

    1. Microbiology and Infectious Disease
    Guoqi Li, Xiaohong Cao ... Shihua Wang
    Research Article

    The target of rapamycin (TOR) signaling pathway is highly conserved and plays a crucial role in diverse biological processes in eukaryotes. Despite its significance, the underlying mechanism of the TOR pathway in Aspergillus flavus remains elusive. In this study, we comprehensively analyzed the TOR signaling pathway in A. flavus by identifying and characterizing nine genes that encode distinct components of this pathway. The FK506-binding protein Fkbp3 and its lysine succinylation are important for aflatoxin production and rapamycin resistance. The TorA kinase plays a pivotal role in the regulation of growth, spore production, aflatoxin biosynthesis, and responses to rapamycin and cell membrane stress. As a significant downstream effector molecule of the TorA kinase, the Sch9 kinase regulates aflatoxin B1 (AFB1) synthesis, osmotic and calcium stress response in A. flavus, and this regulation is mediated through its S_TKc, S_TK_X domains, and the ATP-binding site at K340. We also showed that the Sch9 kinase may have a regulatory impact on the high osmolarity glycerol (HOG) signaling pathway. TapA and TipA, the other downstream components of the TorA kinase, play a significant role in regulating cell wall stress response in A. flavus. Moreover, the members of the TapA-phosphatase complexes, SitA and Ppg1, are important for various biological processes in A. flavus, including vegetative growth, sclerotia formation, AFB1 biosynthesis, and pathogenicity. We also demonstrated that SitA and Ppg1 are involved in regulating lipid droplets (LDs) biogenesis and cell wall integrity (CWI) signaling pathways. In addition, another phosphatase complex, Nem1/Spo7, plays critical roles in hyphal development, conidiation, aflatoxin production, and LDs biogenesis. Collectively, our study has provided important insight into the regulatory network of the TOR signaling pathway and has elucidated the underlying molecular mechanisms of aflatoxin biosynthesis in A. flavus.

    1. Microbiology and Infectious Disease
    Brian G Vassallo, Noemie Scheidel ... Dennis H Kim
    Research Article

    The microbiota is a key determinant of the physiology and immunity of animal hosts. The factors governing the transmissibility of viruses between susceptible hosts are incompletely understood. Bacteria serve as food for Caenorhabditis elegans and represent an integral part of the natural environment of C. elegans. We determined the effects of bacteria isolated with C. elegans from its natural environment on the transmission of Orsay virus in C. elegans using quantitative virus transmission and host susceptibility assays. We observed that Ochrobactrum species promoted Orsay virus transmission, whereas Pseudomonas lurida MYb11 attenuated virus transmission relative to the standard laboratory bacterial food Escherichia coli OP50. We found that pathogenic Pseudomonas aeruginosa strains PA01 and PA14 further attenuated virus transmission. We determined that the amount of Orsay virus required to infect 50% of a C. elegans population on P. lurida MYb11 compared with Ochrobactrum vermis MYb71 was dramatically increased, over three orders of magnitude. Host susceptibility was attenuated even further in the presence of P. aeruginosa PA14. Genetic analysis of the determinants of P. aeruginosa required for attenuation of C. elegans susceptibility to Orsay virus infection revealed a role for regulators of quorum sensing. Our data suggest that distinct constituents of the C. elegans microbiota and potential pathogens can have widely divergent effects on Orsay virus transmission, such that associated bacteria can effectively determine host susceptibility versus resistance to viral infection. Our study provides quantitative evidence for a critical role for tripartite host-virus-bacteria interactions in determining the transmissibility of viruses among susceptible hosts.